ACTIVE CONSORTIA / PROGRAMS
Completed Consortia
C‐Path leads novel transatlantic drug safety effort which yields FDA/EMEA qualification of new drug tests for kidney safety. C‐Path qualifies first set of preclinical safety biomarkers.
Please click to follow the appropriate link below to complete your application
